adalimumab-bwwd

Generic: adalimumab-bwwd

Labeler: cordavis limited
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name adalimumab-bwwd
Generic Name adalimumab-bwwd
Labeler cordavis limited
Dosage Form SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients

adalimumab 40 mg/.4mL

Manufacturer
Cordavis Limited

Identifiers & Regulatory

Product NDC 83457-187
Product ID 83457-187_62d117b6-ce78-4e27-9599-fcde5bc476db
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA761059
Listing Expiration 2026-12-31
Marketing Start 2025-12-12

Pharmacologic Class

Established (EPC)
tumor necrosis factor blocker [epc]
Mechanism of Action
tumor necrosis factor receptor blocking activity [moa]
Chemical Structure
antibodies, monoclonal [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 83457187
Hyphenated Format 83457-187

Supplemental Identifiers

RxCUI
2640425 2640430
UNII
FYS6T7F842
NUI
N0000175610 N0000175451 M0001357

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name adalimumab-bwwd (source: ndc)
Generic Name adalimumab-bwwd (source: ndc)
Application Number BLA761059 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 40 mg/.4mL
source: ndc
Packaging
  • 2 SYRINGE in 1 CARTON (83457-187-01) / .4 mL in 1 SYRINGE (83457-187-99)
source: ndc

Packages (1)

83457-187-01 2 SYRINGE in 1 CARTON (83457-187-01) / .4 mL in 1 SYRINGE (83457-187-99)

Ingredients (1)

adalimumab (40 mg/.4mL)

Linked Drug Pages (1)

Adalimumab-bwwd ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "62d117b6-ce78-4e27-9599-fcde5bc476db", "openfda": {"nui": ["N0000175610", "N0000175451", "M0001357"], "unii": ["FYS6T7F842"], "rxcui": ["2640425", "2640430"], "spl_set_id": ["c24655e5-796e-4127-b716-92f08d649c83"], "pharm_class_cs": ["Antibodies, Monoclonal [CS]"], "pharm_class_epc": ["Tumor Necrosis Factor Blocker [EPC]"], "pharm_class_moa": ["Tumor Necrosis Factor Receptor Blocking Activity [MoA]"], "manufacturer_name": ["Cordavis Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 SYRINGE in 1 CARTON (83457-187-01)  / .4 mL in 1 SYRINGE (83457-187-99)", "package_ndc": "83457-187-01", "marketing_start_date": "20251212"}], "brand_name": "Adalimumab-bwwd", "product_id": "83457-187_62d117b6-ce78-4e27-9599-fcde5bc476db", "dosage_form": "SOLUTION", "pharm_class": ["Antibodies", "Monoclonal [CS]", "Tumor Necrosis Factor Blocker [EPC]", "Tumor Necrosis Factor Receptor Blocking Activity [MoA]"], "product_ndc": "83457-187", "generic_name": "adalimumab-bwwd", "labeler_name": "Cordavis Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Adalimumab-bwwd", "active_ingredients": [{"name": "ADALIMUMAB", "strength": "40 mg/.4mL"}], "application_number": "BLA761059", "marketing_category": "BLA", "marketing_start_date": "20251212", "listing_expiration_date": "20261231"}